Evaluation of leukocyte arylsulphatase a, serum interleukin-6 and urinary heparan sulphate following tamoxifen therapy in breast cancer

Pharmacological Research

Volumn 52, Issue 4, 2005, Pages 340-345

  Öner Iyidoǧan, Yildiz ^a   Öner, Pernur ^a   Koçak, Hikmet ^a   Lama, Abdul ^b   Gürdöl, Figen ^a   Bekpinar, Seldaǧ ^a   Unur, Nurettin ^b   Özbek Kir, Zeynep ^c  

^a ISTANBUL UNIVERSITY   (Turkey)

^b Division of Radiation Oncology   (Turkey)

^c Eyup State Hospital   (Turkey)

Author keywords

Arylsulphatase A; Breast cancer; Heparan sulphate; Interleukin 6; Tamoxifen

Indexed keywords

ARYLSULFATASE; GLYCOSAMINOGLYCAN; HEPARAN SULFATE; INTERLEUKIN 6; LEUKOCYTE ENZYME; TAMOXIFEN;

ADULT; AGED; ARTICLE; BLOOD ANALYSIS; BLOOD SAMPLING; BREAST CANCER; CANCER CHEMOTHERAPY; CARBOHYDRATE ANALYSIS; CHEMICAL ANALYSIS; CHEMICAL PARAMETERS; CLINICAL ARTICLE; CONTROLLED STUDY; CORRELATION ANALYSIS; DISEASE EXACERBATION; DRUG EFFECT; ENZYME ACTIVITY; ENZYME BLOOD LEVEL; FEMALE; HUMAN; MASTECTOMY; MEASUREMENT; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; REMISSION; SHORT COURSE THERAPY; STATISTICAL SIGNIFICANCE; TREATMENT OUTCOME; URINALYSIS; URINE LEVEL;

ADULT; AGED; AGED, 80 AND OVER; ANTICARCINOGENIC AGENTS; ANTINEOPLASTIC AGENTS, HORMONAL; BREAST NEOPLASMS; CEREBROSIDE-SULFATASE; CHEMOTHERAPY, ADJUVANT; FEMALE; GLYCOSAMINOGLYCANS; HEPARITIN SULFATE; HUMANS; INTERLEUKIN-6; LEUKOCYTES; MIDDLE AGED; TAMOXIFEN;

EID: 23844539733     PISSN: 10436618     EISSN: 10961186     Source Type: Journal    
DOI: 10.1016/j.phrs.2005.05.008     Document Type: Article

References (41)

1. L.M. Dzialoszynski, and J. Gniot-Szulzyscka The clinical aspects of arylsulfatase activity Clin Chim Acta 15 1967 381 386
2. L.R. Morgan, M.S. Samuels, W. Thomas, E.T. Krementz, and W. Mecker Arylsulfatase B in colorectal cancer Cancer 36 1975 2337 2345
3. S. Gasa, A. Makita, T. Kameya, T. Kodama, E. Araki, and T. Yoneyama Elevated activities and properties of arylsulfatase A and B-variant in human lung tumors Cancer Res 40 1980 3804 3809
4. Y. Uehara, S. Gasa, A. Makita, K. Sakurada, and T. Miyazaki Lysosomal arylsulfatases of human leukocytes: Increment of phosphorylated B variants in chronic myelogenous leukemia Cancer Res 43 1983 5618 5622
5. K. Mitsuhashi, A. Maru, T. Koyanagi, T. Ishibashi, Y. Imai, and S. Gasa Arylsulfatase A activities in urine and tissues taken from bladder cancer patients Jpn J Exp Med 54 1984 211 216
6. B. Ömer, P. Öner, M. Manyasli, and M. Aktan Leukocyte arylsulfatase A activity in acute leukemia Cancer Biochem Biophys 14 1994 53 56
7. L.M. Dzialoszynski, J.L. Kroll, and A. Fröhlich Arylsulphatase activity of some malignant tumors Clin Chim Acta 14 1966 450 453
8. P. Laidler, D. Kowalski, J. Silberring, and Arylsulfatase A in serum from patients with cancer of various organs Clin Chim Acta 204 1991 69 78
9. S. Türkmen, P. Öner, F. Çinar, H. Koçak, G. Güvenen, and H. Altun Evaluation of leukocyte arylsulfatase A activity in patients with breast cancer and benign breast disease Cancer Lett 166 2001 95 101
10. M.C. Geokas, and H. Rinderknecht Plasma arylsulphatase and β-glucoronidase in acute alcoholism Clin Chim Acta 46 1973 27 32
11. R.J. Kraaijenhagen, G.P.M. Schipper-Kester, G. Rijksen, G.C. de Gast, and G.E.J. Staal Lysosomal enzymes in normal and leukemic B lymphocytes Clin Chim Acta 118 1982 255 263
12. J.R. Pasqualini Role, control and expression of estrone sulfatase and 17-beta-hydroxysteroid dehydrogenase activities in human breast cancer Zentrabl Gynakol 119 1997 48 53
13. S.P. Newman, A. Purohit, M.W. Ghilchik, B.V.L. Potter, and M.J. Reed Regulation of steroid sulphatase expression and activity in breast cancer J Steroid Biochem Molec Biol 75 2000 259 264
14. T. Nakata, S. Takashima, Y. Shiotsu, C. Murakata, H. Ishida, and S. Akinaga Role of steroid sulfatase in local formation of estrogen in postmenopausal breast cancer patients J Steroid Biochem Molec Biol 86 2003 455 460
15. Y. Miyoshi, A. Ando, S. Hasegawa, M. Ishitobi, T. Toguchi, and Y. Tamaki High expression of steroid sulfatase mRNA predicts poor prognosis in patients with estrogen receptor-positive breast cancer Clin Cancer Res 9 2003 2288 2293
16. V. Speirs, D.S. Walton, M.C. Hall, and S.L. Atkin In vivo and in vitro expression of steroid converting enzymes in human breast tumours: associations with interleukin-6 Br J Cancer 81 1999 690 695
17. R.M. Harris, D.M. Wood, L. Bottomley, S. Blagg, K. Owen, and P.J. Hughes Phytoestrogens are potent inhibitors of estrogen sulfation: implications for breast cancer risk and treatment J Clin Endocrinol Metab 89 2004 1779 1787
18. Y. Kuang, Z. Zhang, and X. Zhang Interleukin-6 and its soluble receptors in human breast cancer Chung Hua Chung Liu Tsa Chih 20 1998 305 307
19. S. Honma, K. Shimodaira, Y. Shimizu, N. Tsuchiya, H. Saito, and T. Yanaihara The influence of inflammatory cytokines on estrogen production and cell proliferation in human breast cancer cells Endocr J 40 2002 371 377
20. V. Speirs, M.J. Kerin, D.S. Walton, C.S. Newton, S.B. Desai, and S.L. Atkin Direct activation of oestrogen receptor-alpha by interleukin-6 in primary cultures of breast cancer epithelial cells Br J Cancer 82 2000 1312 1316
21. A. Purohit, S.P. Newman, and M.J. Reed The role of cytokines in regulating estrogen synthesis: implications for the etiology of breast cancer Breast Cancer Res 4 2002 65 69
22. M. Iwamori, H.W. Moser, and Y. Kishimoto Solubulization and partial purification of steroid sulphatase from rat liver: characterization of estrone sulphatase Arch Biochem Biophys 174 1976 199 208
23. C.E. Bird, V. Masters, E.E. Sterns, and A.F. Clark Effects of Tamoxifen on testosteron metabolism in postmenopausal women with breast cancer Clin Invest Med 8 1985 97 102
24. L.R. Morgan Jr., P.S. Schein, P.V. Wooley, D. Hoth, J. Macdonald, and M. Lippman Therapeutic use of tamoxifen in advanced breast cancer: correlation with biochemical parameters Cancer Treat Rep 60 1976 1437 1443
25. C.W. Buermann, A.I. Oronsky, and M.I. Horowitz Chondroitin sulfate degrading enzymes in human polymorphonuclear leukocytes Arch Biochem Biophys 193 1979 277 283
26. V. Lambrecht, X. Le Bourhis, and R.A. Toillon Alterations in both heparan sulfate proteoglycans and mitogenic activity of fibroblast growth factor-2 are triggerred by inhibitors of proliferation in normal and breast cancer epithelial cells Exp Cell Res 245 1998 239 244
27. N. Sunil, N. Srinivasan, M.M. Aruldhas, and P. Govindarajulu Impact of oestradiol and progesterone on the glycosaminoglycans and their depolymerizing enzymes of the rat mammary gland Acta Physiol Scand 168 2000 385 392
28. L. Henry, B. Angus, T.W.J. Lennard, C. Hennessy, C. Wright, and J.A. Henry New monoclonal antibodies to oestrogen and porgesterone receptor: characterisation and clinical studies in human. breast cancer J Pathol Suppl 169 1993 168A
29. H. Pilz Late adult metachromatic leukodystrophy Arch Neurol 27 1972 87 90
30. O.H. Lowry, N.J. Roseborough, A.L. Farr, and R.J. Randall Protein measurement with the Folin phenol reagent J Biol Chem 193 1951 265 275
31. C.H.A. Van de Lest, E.M.M. Versteeg, J.H. Veerkamp, J.H. Berden, J. Van den Born, and L. Huenks Altered composition of urinary heparan sulfate in patients with COPD Am J Respir Crit Care Med 154 1996 952 958
32. A.R. Butler The Jaffé reaction: identification of coloured species Clin Chim Acta 59 1976 227 232
33. K. Honke, T. Fujii, and A. Makita Arylsulfatase A protein in sera of cancer patients Cancer J 8 1995 139 142
34. A. Wozniak, T. Drewa, M. Rozwodowska, G. Drewa, W. Lambrecht, and I. Wisniewska Activity of some lysosomal enzymes in serum and in tumors of patients with squamous cell lung carcinoma Neoplasma 49 2002 10 15
35. D. Conze, L. Weiss, P.S. Regen, A. Bushhan, D. Weaver, and P. Johnson Autocrine production of interleukin 6 causes multidrug resistance in breast cancer cells Cancer Res 61 2001 8851 8888
36. R. Salgado, S. Junius, I. Benoy, P. Van Dam, P. Vermeulen, and E. Van Marck Circulating interleukin-6 predicts survival in patients with metastatic breast cancer Int J Cancer 103 2003 642 646
37. T. Bachelot, I. Ray-Coquard, C. Menetrier-Caux, M. Rastkha, A. Duc, and J.-Y. Blay Prognostic value of serum levels of interleukin 6 and of serum and plasma levels of vascular endothelial growth factor in hormone-refractory metastatic breast cancer patients Br J Cancer 88 2003 1721 1726
38. R.D. Sanderson Heparan sulfate proteoglycans in invasion and metastasis Cell Dev. Biol. 12 2001 89 98
39. S. Kure, O. Yoshie, and H. Aso Metastatic potential of murine B16 melanoma correlates with reduced surface heparan sulfate glycosaminoglycan Jpn J Cancer Res 78 1987 1238 1245
40. M.J. Stanley, M.W. Stanley, R.D. Sanderson, and R. Zera Syndecan-1 expression is induced in the stroma of infiltrating breast carcinoma Am J Clin Pathol 112 1999 377 383
41. C. Seidel, A. Sundan, M. Hjörth, I. Turesson, I.M. Dahl, and N. Abilgaard Serum syndecan-1: a new independent prognostic marker in multiple myeloma Blood 15 2000 388 392